Elutia Inc.

ELUT Healthcare Medical Devices

Elutia Inc.’s revenue for fiscal 2025 (year ended December 2025) was $12.3 million, down 15.0% from fiscal 2024.

Revenue
−11.7%
EPS
+26.1%
Free cash flow
−2.52%

Quarter to June 2026, against a year earlier

0.85 0.10 +13.33%
Market cap
$33.3M
P/E
0.7×
Fwd P/E
−1.3×
Dividend yield
—
F-score
5/9
Altman Z
−4.10
Beneish M
0.81
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
5 5 5 1

+8 more TTM periods

ROE
(454.01%) (822.31%) (654.34%) 62.39%
ROA
152.89% 121.21% 123.51% (67.48%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
310.30% 206.22% 183.23% 125.60%
Average Days of Receivables
399.77 451.74 432.90 204.40
Free Cash Flow per Share
(1.04) (1.07) (1.13) (0.79)
Free Cash Flow
(46.03) (45.82) (46.69) (33.37)
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026